JALYN

Identification of Jalyn

No description

Google image searchProduct monograph

Active ingredients

dutasteride, 0.5 MG

tamsulosin hydrochloride, 0.4 MG

DIN: 02372010

Dosage form(s): CAPSULE (IMMEDIATE AND EXTENDED RELEASE)

Route(s) of administration: ORAL

Description: MODIFIED-RELEASE CAPSULE (DUTASTERIDE: IMMEDIATE RELEASE, AND TAMSULOSIN HCL: EXTENDED RELEASE)

Schedule: Prescription

Company: GLAXOSMITHKLINE INC

Date: 17-NOV-2011

ATC:

• G04 — UROLOGICALS (ATC, ATC/DDD, )
• G04C — DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY (ATC, ATC/DDD)
• G04CA — Alpha-adrenoreceptor antagonists (ATC, ATC/DDD)
• G04CA52 — TAMSULOSIN AND DUTASTERIDE (ATC/DDD)

Reference brand drug: Jalyn

External Links for Jalyn

Search on Google

• Jalyn side effects
• Jalyn dosage
• dutasteride side effects
• dutasteride dosage
• tamsulosin hydrochloride side effects
• tamsulosin hydrochloride dosage

Glaxosmithkline Inc

Go to GlaxoSmithKline website to see drug product details. Sometimes you can find jalyn photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.